Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2015

01-12-2015 | Original Article

Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population

Authors: J. F. C. Woods, J. A. De Marchi, A. J. Lowery, A. D. K. Hill

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2015

Login to get access

Abstract

Background

Sentinel lymph node (SLN) positivity is an important prognostic factor in cutaneous melanoma. A nomogram has been developed at Memorial Sloan-Kettering Cancer Centre (MSKCC) to predict SLN positivity and this may be useful to select patients for SLN biopsy.

Aims

We aimed to determine whether this nomogram would be of clinical use in an Irish population.

Methods

Age, Breslow thickness, Clark’s level, presence of ulceration and tumour location indices were used to calculate the probability of SLN positivity with the MSKCC nomogram in 124 patients who underwent SLN biopsy in Beaumont Hospital between 2006 and 2012. Discrimination and calibration of the nomogram were evaluated. Negative predictive value (NPV) of the nomogram was calculated, using a cut-off of nomogram predicted probability of <9 %.

Results

SLN biopsy was positive in 25 patients (20.16 %). Overall predictive accuracy of the nomogram was found to be significant with an area under the curve of 0.805 (95 % confidence interval 0.710–0.899). The mean predicted probability correlated well with observed risk (r = 0.887). The NPV was 92.86 % with an error rate of 3.23 %. This would lead to a reduction in SLN biopsy rate of 45.16 %.

Conclusions

This nomogram is valid and accurate at predicting SLN positivity in an Irish population. This may facilitate the clinical decision to perform a SLN biopsy in malignant melanoma.
Literature
2.
go back to reference Forsea AM, Del Marmol V, de Vries E et al (2012) Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol 167:1124–1130CrossRefPubMed Forsea AM, Del Marmol V, de Vries E et al (2012) Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol 167:1124–1130CrossRefPubMed
3.
go back to reference Doubrovsky A, De Wilt JH, Scolyer RA et al (2004) Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 11:829–836CrossRefPubMed Doubrovsky A, De Wilt JH, Scolyer RA et al (2004) Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 11:829–836CrossRefPubMed
4.
go back to reference Phan GQ, Messina JL, Sondak VK, Zager JS (2009) Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control J Moffitt Cancer Cent 16:234–239 Phan GQ, Messina JL, Sondak VK, Zager JS (2009) Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control J Moffitt Cancer Cent 16:234–239
5.
go back to reference Morton DL (2012) Overview and update of the phase III multicenter selective lymphadenectomy trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 29:699–706PubMedCentralCrossRefPubMed Morton DL (2012) Overview and update of the phase III multicenter selective lymphadenectomy trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 29:699–706PubMedCentralCrossRefPubMed
6.
go back to reference Bleicher RJ, Essner R, Foshag LJ et al (2003) Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 21:1326–1331CrossRefPubMed Bleicher RJ, Essner R, Foshag LJ et al (2003) Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 21:1326–1331CrossRefPubMed
7.
go back to reference Jacobs IA, Chang CK, DasGupta TK, Salti GI (2003) Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma. Ann Surg Oncol 10:558–561CrossRefPubMed Jacobs IA, Chang CK, DasGupta TK, Salti GI (2003) Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma. Ann Surg Oncol 10:558–561CrossRefPubMed
8.
go back to reference Testori A, De Salvo GL, Montesco MC et al (2009) Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 16:2018–2027CrossRefPubMed Testori A, De Salvo GL, Montesco MC et al (2009) Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 16:2018–2027CrossRefPubMed
10.
go back to reference Wong SL, Kattan MW, McMasters KM, Coit DG (2005) A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol 12:282–288CrossRefPubMed Wong SL, Kattan MW, McMasters KM, Coit DG (2005) A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol 12:282–288CrossRefPubMed
11.
go back to reference White RL Jr, Ayers GD, Stell VH et al (2011) Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol 18:3593–3600PubMedCentralCrossRefPubMed White RL Jr, Ayers GD, Stell VH et al (2011) Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol 18:3593–3600PubMedCentralCrossRefPubMed
12.
go back to reference Piñero A, Canteras M, Ortiz E et al (2008) Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma. Ann Surg Oncol 15:2874–2877CrossRefPubMed Piñero A, Canteras M, Ortiz E et al (2008) Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma. Ann Surg Oncol 15:2874–2877CrossRefPubMed
13.
go back to reference Pasquali S, Mocellin S, Campana LG et al (2011) Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. Eur J Surg Oncol 37:675–680CrossRefPubMed Pasquali S, Mocellin S, Campana LG et al (2011) Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. Eur J Surg Oncol 37:675–680CrossRefPubMed
14.
go back to reference Vergouwe Y (2003) Validation of Clinical Prediction Models: Theory and Applications in Testicular Germ Cell Cancer. Thesis, Erasmus University Rotterdam Vergouwe Y (2003) Validation of Clinical Prediction Models: Theory and Applications in Testicular Germ Cell Cancer. Thesis, Erasmus University Rotterdam
15.
go back to reference Morton DL, Thompson JF, Cochran AJ et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599–609PubMedCentralCrossRefPubMed Morton DL, Thompson JF, Cochran AJ et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599–609PubMedCentralCrossRefPubMed
16.
go back to reference Sabel MS, Rice JD, Griffith KA et al (2012) Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy. Ann Surg Oncol 19:287–293PubMedCentralCrossRefPubMed Sabel MS, Rice JD, Griffith KA et al (2012) Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy. Ann Surg Oncol 19:287–293PubMedCentralCrossRefPubMed
Metadata
Title
Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population
Authors
J. F. C. Woods
J. A. De Marchi
A. J. Lowery
A. D. K. Hill
Publication date
01-12-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1166-4

Other articles of this Issue 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.